PanTher Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.94M

  • Investors
  • 15

PanTher Therapeutics General Information

Description

Developer of proprietary cancer treatment technology designed to enhance therapeutic response with minimal side effects. The company's adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug's full potential through direct, sustained treatment at the tumor site, enabling medical professionals to take on the fatal cancers to treat with a lead investigational candidate in pancreatic cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • 191 Dexter Avenue
  • Watertown, MA 02472
  • United States
+1 (857) 000-0000

PanTher Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PanTher Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 16-Dec-2023 $3.94M 000.00 Completed Clinical Trials - Phase 1
10. Accelerator/Incubator 06-Jun-2023 00.000 Completed Clinical Trials - Phase 1
9. Grant 22-Aug-2022 000.00 00.000 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series A) 23-Jun-2022 00.000 00.000 000.00 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series A) 19-May-2021 00.000 00.000 00.00 Completed Pre-Clinical Trials
6. Accelerator/Incubator 0000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 04-Mar-2016 0000 Completed Startup
4. Accelerator/Incubator 02-Nov-2015 0000 Completed Startup
3. Seed Round 08-Jun-2015 $95K $95K Completed Startup
2. Accelerator/Incubator 07-May-2015 Completed Startup
To view PanTher Therapeutics’s complete valuation and funding history, request access »

PanTher Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view PanTher Therapeutics’s complete cap table history, request access »

PanTher Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of proprietary cancer treatment technology designed to enhance therapeutic response with minimal side effects.
Drug Discovery
Watertown, MA
10 As of 2022
000.00
0000000000 0 000.00

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
0000 000000000
Los Altos, CA
00 As of 0000
000.00
000000000 000.00

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 00000000
Westminster, CO
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PanTher Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RenovoRx Formerly VC-backed Los Altos, CA 00 000.00 000000000 000.00
TriSalus Life Sciences Formerly VC-backed Westminster, CO 000 00000 000000000 00000
Focal Medical Venture Capital-Backed Cary, NC 00 00.000 0000000000 00.000
You’re viewing 3 of 3 competitors. Get the full list »

PanTher Therapeutics Patents

PanTher Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240024644-A1 Tissue penetrating and biodegradable drug delivery devices and methods of use thereof Pending 22-Jul-2022 0000000000
US-20230149299-A1 Implantable and biodegradable drug delivery devices and methods of use thereof Pending 17-Nov-2021 0000000000

PanTher Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Laura Indolfi Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Elazer Edelman Ph.D Scientific Co-Founder
David Ting MD Scientific Co-Founder & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

PanTher Therapeutics Board Members (8)

Name Representing Role Since
Daniel Wildman Self Strategic Advisor & Board Member 000 0000
Darshana Zaveri Catalyst Health Ventures Board Member 000 0000
David Mackey JD Catalyst Health Ventures Corporate Finance Advisor and Board Observer 000 0000
David Ting MD Self Scientific Co-Founder & Board Member 000 0000
John Edwards Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

PanTher Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanTher Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keiretsu Forum Angel Group Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
Cancer Prevention and Research Institute of Texas Government 000 0000 000000 0
Angel Physicians Fund Angel Group Minority 000 0000 000000 0
Catalyst Health Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »